McKinsey reaches $573 million multistate settlement over opioid consulting work
Company: McKinsey & Company
Summary
In February 2021, McKinsey & Company agreed to pay $573 million to settle investigations by 47 U.S. states, the District of Columbia, and five U.S. territories into its consulting work for opioid manufacturers, including Purdue Pharma. According to the state attorneys general, McKinsey advised opioid companies on strategies to increase sales while the opioid crisis worsened. As part of the settlement, McKinsey agreed to fund opioid treatment, prevention, and recovery programs and to publicly release internal documents related to its opioid consulting work. McKinsey stated that the settlement resolved the investigations without any admission of wrongdoing or liability.